Travere Therapeutics Inc. (TVTX)
19.75
-1.65 (-7.71%)
At close: Mar 03, 2025, 3:59 PM
19.80
0.28%
After-hours: Mar 03, 2025, 04:05 PM EST
Travere Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -320.63M | -376.33M | -278.48M | -180.09M | -169.43M | -146.43M | -102.68M | -59.73M | -47.9M | 117.24M | -110.94M | -33.82M | -30.34M | -14.82K | -23.02K | -27.98K | -18.27K |
| Depreciation & Amortization | 43.55M | 38.53M | 33.08M | 26.62M | 24.58M | 20.41M | 18.67M | 17.8M | 16.14M | 13.39M | 5.4M | 215.99K | 124.89K | n/a | 8.33K | 12.5K | n/a |
| Stock-Based Compensation | 36.91M | 44.25M | 38.14M | 29.57M | 23.61M | 21.11M | 19.77M | 26.87M | 29.1M | 25.9M | 15.9M | 1.42M | 17.56M | n/a | n/a | n/a | n/a |
| Other Working Capital | n/a | 446K | 1.34M | 79.08M | -17.24M | 567K | 16.4M | -2.08M | 2.2M | -9.07M | 237.13K | -1.35M | 2.43M | n/a | n/a | -2K | 19.51K |
| Other Non-Cash Items | 2.69M | 39.01M | 19.03M | 23.82M | 102.54M | 2.73M | 7.86M | 25.07M | 18.26M | -130.14M | 33.95M | 13.03M | 6.81M | 12.78K | 12K | -2K | 18.27K |
| Deferred Income Tax | n/a | n/a | n/a | 4.12M | 1.99M | 41.29M | 20.34M | -6.42M | -22.66M | -15.57M | -2.46M | 75.78K | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | -25.48M | 904K | 79.98M | -26.04M | 2.68M | 11.07M | 3.81M | 5.47M | -11.37M | 12.3M | 1.49M | 3.11M | 2K | 2K | 2K | -19.51K |
| Operating Cash Flow | -237.47M | -280.02M | -186.29M | -14.79M | -42.74M | -58.21M | -24.96M | 7.4M | -1.6M | -554K | -45.85M | -17.59M | -2.74M | -49 | -689 | -15.48K | -18.27K |
| Capital Expenditures | -101.21M | -668K | -28.56M | -24.15M | -119.84M | -15.56M | -19.7M | -14.01M | -11.92M | -7.03M | -3.96M | -5.55M | -1.19M | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | 19.05M | 113.08M | 15.37M | -15M | -13.12M | -500K | -33.43M | -29.15M | -5.43M | 3.72K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -125.76M | -443.94M | -385.39M | -547.08M | -214.96M | -223.71M | -331.35M | -102.42M | -184.11M | -198.53M | -18.05M | -6.99M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 326.33M | 334.57M | 381.99M | 433.6M | 273.48M | 259.14M | 162.75M | 114.53M | 159.52M | 9.98M | 13.99M | 8.58M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -101.25M | 165.81M | -600K | -19.05M | -113.08M | -15.37M | -202.56M | 60.62M | 47.38M | 148.41M | -92.96K | 3.99M | -510.45K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 99.33M | 55.78M | -32.55M | -137.62M | -61.33M | 19.86M | -203.29M | 45.6M | 10.37M | -80.6M | -37.26M | -5.41M | -1.7M | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | 95.04M | n/a | n/a | n/a | 235.8M | n/a | n/a | -45M | 54.01M | -897.96K | 884.76K | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.26M | -958K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.68M | 27.55M | 2.98M | 6.75M | -3.81M | -2.08M | -3.93M | 5.45M | -5.69M | -2.88M | 3.57M | -100.04K | 77.2K | n/a | n/a | n/a | 25K |
| Financial Cash Flow | 139.42M | 218.75M | 117.57M | 231.68M | 127.71M | -2.08M | 231.86M | 5.45M | -5.69M | 100.77M | 95.32M | 28.98M | 4.44M | n/a | n/a | n/a | 25K |
| Net Cash Flow | 359K | -3.51M | -104.06M | 80.98M | 22.34M | -40.44M | 3.48M | 58.39M | 3.2M | 19.6M | 12.21M | 5.99M | 1.33K | -49 | -689 | -124 | 6.73K |
| Free Cash Flow | -338.69M | -322.28M | -214.85M | -38.94M | -162.59M | -73.78M | -44.66M | -6.61M | -13.52M | -7.58M | -49.81M | -23.14M | -3.93M | -49 | -689 | -15.48K | -18.27K |